On December 19, 2023, the Board of Eterna Therapeutics Inc. appointed James Bristol as chairman of the Board, effective immediately, to serve until his successor is duly elected and qualified, or until his earlier resignation or removal. As previously disclosed, Mr. Bristol has served on the Board since October 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | +3.12% | -16.75% | -0.28% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-0.28% | 9.68M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ERNA Stock
- News Eterna Therapeutics Inc.
- Eterna Therapeutics Inc. Appoints James Bristol as Chairman of the Board